share_log

Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Noonberg Sarah B.

Marinus Pharmaceuticals | 4:持股變動聲明-董事 Noonberg Sarah B.

SEC announcement ·  2023/05/17 21:08
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息